Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1740-2024Class II

The Distal Access Catheter is a single-lumen, braided shaft, variable stiffness catheter with radiopaque...

Stryker Corp. / initiated 2024-04-03 / Open, Classified / root cause: sterility

Stryker Neurovascular began a recall of The Distal Access Catheter is a single-lumen, braided shaft, variable stiffness catheter with radiopaque marker on the distal end and a luer hub on the... on . FDA classified it as Class II and gives the reason as "Stryker Neurovascular is recalling their DAC- Distal Access Catheter -038 136cm, a Distal Access Catheter by removal. The reason for the recall is: the DAC Lot #0000486382 was released with out-of-specification...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as sterility.

Recall record

Recall number
Z-1740-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Stryker Corp.
Product
The Distal Access Catheter is a single-lumen, braided shaft, variable stiffness catheter with radiopaque marker on the distal end and a luer hub on the proximal end. The catheter shaft has a hydrophilic coating to reduce friction during use. Device dimensions and configuration are shown on the product label. A rotating hemostasis valve with side-arm adapter is provided with each catheter. The rotating hemostasis valve is typically y shaped with a female luer lock and a manual hemostasis valve. The female port allows for aspiration and contrast injections while the hemostasis valve allows direct arterial access when using other devices such as guidewires and/or interventional devices.
Product code
DQY Catheter, Percutaneous
Reason for recall
Stryker Neurovascular is recalling their DAC- Distal Access Catheter -038 136cm, a Distal Access Catheter by removal. The reason for the recall is: the DAC Lot #0000486382 was released with out-of-specification endotoxin results.
Root cause tag
sterility
FDA root cause
Release of Material/Component prior to receiving test results
Action
On 4/3/24, recall notices were mailed to Supply Chain Management/ Recall Coordinator/ Inventory Managers informing them: 1) Segregate the affected units in a secure location for return to the firm. Circulate this Recall-Removal notice internally to all interested/affected parties. 2) Maintain awareness of this communication internally until all required actions have been completed within your facility. 3) Inform the firm if any of the subject devices have been distributed to other organizations. If yes, provide contact details so the firm can inform the recipients appropriately. 4) Inform the firm of any adverse events concerning the use of the subject devices. (US Customer Service: 1-855-91-NEURO (1-855-916-3876), Email: [email protected]) 5) Complete and return the customer response form to [email protected]
Quantity in commerce
43
Distribution
US Nationwide distribution in the states of TX, FL, NJ, CO, LA, NC, AL, PA, MI, MS, SC, IL.
Product codes and lots
UDI-DI: 07613327313895, Lot: 0000486382, Expiration: 17-Jul-2025

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1740-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1740-2024Class IIOngoingVoluntary: Firm initiated